ACTIVE

ENDODERM

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
199,2 k €
+390.9% YoY
Revenue
744,1 k €
+27.7% YoY
Equity
519 k €
-23.6% YoY

What does ENDODERM do?

ENDODERM is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Pont-à-Celles.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0655.942.209
Incorporation
06/06/2016
Legal form
Private limited company
Registered office
Rue de Seneffe(OB) 3
6230 Pont-à-Celles · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Activities (NACE)
86220Specialist medical practice activities· main86220Specialist medical practice activities
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120202019201820172016
Income statement
Revenue744,1 k €582,8 k €524,7 k €646,3 k €598,2 k €601 k €–549,8 k €439,6 k €–
EBITDA351,8 k €129,7 k €163,8 k €282,4 k €252,4 k €286,1 k €272,1 k €202,1 k €110,7 k €79 k €
Operating result304,5 k €77,6 k €120,7 k €244,6 k €217,6 k €252,4 k €239,8 k €173,7 k €68,6 k €8,5 k €
Net result199,2 k €40,6 k €79,3 k €160,4 k €139,2 k €165,7 k €152,9 k €105,4 k €34,4 k €908,2 €
Balance sheet
Equity519 k €679 k €779,2 k €739,9 k €604,8 k €465,6 k €299,9 k €147 k €41,6 k €7,1 k €
Total assets1,2 M €1,1 M €961,3 k €944,6 k €805,3 k €719,7 k €590,9 k €433,9 k €360 k €350,7 k €
Cash452 k €392,7 k €621,6 k €583,8 k €522,7 k €409 k €231,3 k €75,7 k €29 k €24,5 k €
Debts677,5 k €427,4 k €182,1 k €204,7 k €200,5 k €254,1 k €289,9 k €285 k €316,5 k €342,2 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 7 ended

Active mandates

CAROLE BOURMORCK

Administrator - manager

Active
TANGUY METZ

Administrator - manager

Active

Ended mandates

CAROLE BOURMOCH

Director

Ended
CAROLE BOURMOCH

Manager

Ended
CAROLE BOURMOCK

Director

Ended
CAROLE BOURMORCHX

Manager

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/07/202628/07/202505/08/202416/08/202308/07/202217/06/2021
General meeting30/06/202614/07/202531/07/202431/07/202301/06/202201/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

10 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202623/07/2026FrenchPDF
Abridged model31/12/202414/07/202528/07/2025FrenchPDF
Abridged model31/12/202331/07/202405/08/2024FrenchPDF
Abridged model31/12/202231/07/202316/08/2023FrenchPDF
Abridged model31/12/202101/06/202208/07/2022FrenchPDF
Abridged model31/12/202001/06/202117/06/2021FrenchPDF
Abridged model31/12/201901/06/202014/06/2020FrenchPDF
Abridged model31/12/201801/06/201907/06/2019FrenchPDF
Abridged model31/12/201701/06/201821/06/2018FrenchPDF
Abridged model31/12/201601/06/201713/07/2017FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 7 ended

Active mandates

CAROLE BOURMORCK

Administrator - manager

Active
TANGUY METZ

Administrator - manager

Active

Ended mandates

CAROLE BOURMOCH

Director

Ended
CAROLE BOURMOCH

Manager

Ended
CAROLE BOURMOCK

Director

Ended
CAROLE BOURMORCHX

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates03/07/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/06/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Other12/01/2017
    DIVERS
    PDF
  • Mandates28/10/2016
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Other08/06/2016
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025199,2 k €↑
  2. 2024
    Annual accounts 202440,6 k €↓
  3. 2023
    Annual accounts 202379,3 k €↓
  4. 2023
    Name changeENDODEM SRL
  5. 2022
    Annual accounts 2022160,4 k €↑
  6. 2021
    Annual accounts 2021139,2 k €↓
  7. 2021
    Name changeENDODERM srl
  8. 2020
    Annual accounts 2020165,7 k €↑
  9. 2019
    Annual accounts 2019152,9 k €↑
  10. 2018
    Annual accounts 2018105,4 k €↑
  11. 2017
    Annual accounts 201734,4 k €↑
  12. 2016
    Annual accounts 2016908,2 €
  13. 06/06/2016
    IncorporationPrivate limited company